Xenetic Biosciences, Inc.
XBIO
$3.99
$0.112.84%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.63% | -1.57% | 7.15% | 16.79% | 27.09% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.63% | -1.57% | 7.15% | 16.79% | 27.09% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 5.63% | -1.57% | 7.15% | 16.79% | 27.09% |
| SG&A Expenses | -6.69% | -4.06% | 5.67% | 1.73% | -5.51% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -11.66% | -4.97% | -4.10% | 12.66% | -7.85% |
| Operating Income | 20.35% | 6.90% | 9.59% | -10.69% | 19.03% |
| Income Before Tax | 17.99% | 4.22% | 8.29% | -11.97% | 23.08% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 17.99% | 4.22% | 8.29% | -11.97% | 23.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 17.99% | 4.22% | 8.29% | -11.97% | 23.08% |
| EBIT | 20.35% | 6.90% | 9.59% | -10.69% | 19.03% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 18.38% | 4.98% | 9.56% | -9.03% | 27.31% |
| Normalized Basic EPS | 18.38% | 4.98% | 9.56% | -9.03% | 27.31% |
| EPS Diluted | 18.29% | 4.89% | 9.58% | -8.98% | 27.36% |
| Normalized Diluted EPS | 18.38% | 4.98% | 9.56% | -9.03% | 27.31% |
| Average Basic Shares Outstanding | 0.49% | 0.86% | 1.34% | 2.90% | 4.69% |
| Average Diluted Shares Outstanding | 0.49% | 0.86% | 1.34% | 2.90% | 4.69% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |